4890 Federal Register / Vol. 87, No. 20 / Monday, January 31, 2022 / Notices 

acip/meetings/ no later than 11:59 p.m., 

EST, February 21, 2022, according to the 

instructions provided. 

If the number of persons requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

time, CDC will conduct a lottery to 

determine the speakers for the 

scheduled public comment session. 

CDC staff will notify individuals 

regarding their request to speak by email 

by February 22, 2022. To accommodate 

the significant interest in participation 

in the oral public comment session of 

ACIP meetings, each speaker will be 

limited to 3 minutes, and each speaker 

may only speak once per meeting. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–01820 Filed 1–28–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–22–22CB; Docket No. CDC–2022– 

0011] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

Agencies the opportunity to comment 

on a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Assessment for the Get Ahead of 

Sepsis (GAOS) Consumer Campaign. 

This assessment collects on-line survey 

data from target consumer groups and 

healthcare professionals (HCP) before 

and after the campaign. 

DATES: CDC must receive written 

comments on or before April 1, 2022. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2022– 

0011 by either of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal Agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Assessment for the Get Ahead of 

Sepsis (GAOS) Consumer Campaign— 

New—National Center for Emerging and 

Zoonotic Infectious Diseases (NCEZID), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

Sepsis is a life threating emergency, 

and it is the body’s overactive and toxic 

response to an infection. Each year 1.7 

million adults in the United States 

develop sepsis, with 270,000 fatalities. 

Sepsis is the leading cause of death in 

hospitals and one out of three hospital 

fatalities are due to sepsis infection. 

Sepsis management in U.S. hospitals is 

the highest when compared to inpatient 

cost for all other medical conditions. 

Annual costs are estimated to be over 

$62 billion. 

In media and public health 

campaigns, antimicrobial resistance and 

sepsis are rarely presented together 

which does not make their linkage 

apparent. It has been concluded that 

sepsis and antimicrobial stewardship 

should not be discussed in isolation. 

Surprisingly, 24 percent of adults in the 

U.S. have never heard of sepsis, so this 

presents a unique opportunity for future 

messaging campaigns. 

The goals of the GAOS educational 

campaign are to prevent and reduce 

infections that lead to sepsis and to 

optimize healthcare quality and patient 

safety by raising awareness, knowledge, 

and motivating behavior change related 

to sepsis prevention, early recognition, 

and appropriate treatment among 

consumer target audiences. A panel 

survey will be utilized to recruit 

participants. Surveys will be distributed 

to consumer target groups and HCPs 

both before and after the media 

campaign and partner outreach. 

Consumer audiences include: 

(1) Cancer patients and their 

caregivers (English speaking), 

(2) Patients who survived severe 

COVID–19 or sepsis and their caregivers 

(English speaking), 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 20 / Monday, January 31, 2022 / Notices 4891 

(3) Women who care for a young child 

(children ages 12 and younger; English 

speaking), 

(4) Women who care for a young child 

(children ages 12 and younger; Spanish 

speaking), 

(5) Women who care for an aging 

parent 65+ (English speaking), 

(6) Women who care for an aging 

parent 65+ (Spanish speaking), 

(7) Men aged 65+ with one or more 

chronic conditions (English speaking), 

and 

(8) Healthy adults 65+ (English 

speaking). 

HCP audiences include: 

(1) Emergency Medical Services 

personnel (English speaking), 

(2) Nurse Practitioners and Physician 

Assistants who work at urgent care 

clinics (English speaking), 

(3) Emergency Department triage 

nurses (English speaking), 

(4) General medical ward staff 

(English speaking), 

(5) Primary care physicians (English 

speaking), 

(6) Long-term care (LTC) nurses 

(English speaking), and 

(7) LTC medical technicians and 

sitters (English speaking). 

This program evaluation will assist 

CDC in determining if the media 

campaign, along with partner outreach, 

was successful in changing awareness, 

knowledge, and behaviors of consumers 

and HCPs in select target markets. The 

data collected will also be used to 

inform future refinement and 

implementation of the campaign 

(materials and tactics). 

CDC requests OMB approval for an 

estimated 68 annual burden hours. 

There are no costs to respondents other 

than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses 

per 

respondent 

Average 

burden 

per 

response 

(in hours) 

Total burden 

(in hours) 

Consumer .............................. Get Ahead of Sepsis Consumer Pre-test .... 50 1 20/60 17 

Consumer .............................. Get Ahead of Sepsis Consumer Post-test ... 50 1 20/60 17 

HCPs ..................................... Get Ahead of Sepsis HCP Campaign Pretest.50 1 20/60 17 

HCPs ..................................... Get Ahead of Sepsis HCP Campaign Posttest.50 1 20/60 17 

Total ............................... ....................................................................... ........................ ........................ ........................ 68 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–01885 Filed 1–28–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–22–0978; Docket No. CDC–2022– 

0012] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Emerging Infections Program 

(EIP). EIP is a population-based 

surveillance system designed to collect 

information via active, laboratory case 

finding that is used for detecting, 

identifying, and monitoring emerging 

pathogens. 

DATES: CDC must receive written 

comments on or before April 1, 2022. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2022– 

0012 by either of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 


khammond on DSKJM1Z7X2PROD with NOTICES